• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Inphact gains $15 million investment from MDS

Article

Inphact gains $15 million investment from MDSMDS, a Canadian provider of laboratory and clinical services and products, has invested $15 million in Inphact, a Nashville, TN-based firm providing imaging and teleradiology services over the

Inphact gains $15 million investment from MDS

MDS, a Canadian provider of laboratory and clinical services and products, has invested $15 million in Inphact, a Nashville, TN-based firm providing imaging and teleradiology services over the Internet. The investment is intended to enable MDS to provide Inphact services on an exclusive basis in Canada and to MDS joint-venture facilities in the U.S. Inphact claims to be the first application service provider in the imaging market and is offering its PACS on a subscription basis over an ASP platform. The foundation of the firm’s platform is RadWeb, which provides browser-based access to radiology images and reports and the ability to manipulate and enhance digital images. Inphact plans to develop its ASP product for other imaging modalities, starting with cardiology.

Recent Videos
Can an Emerging AI Software for DBT Help Reduce Disparities in Breast Cancer Screening?
Skeletal Muscle Loss and Dementia: What Emerging MRI Research Reveals
Magnetoencephalopathy Study Suggests Link Between Concussions and Slower Aperiodic Activity in Adolescent Football Players
Radiology Study Finds Increasing Rates of Non-Physician Practitioner Image Interpretation in Office Settings
Assessing a Landmark Change in CMS Reimbursement for Diagnostic Radiopharmaceuticals
Addressing the Early Impact of National Breast Density Notification for Mammography Reports
2 KOLs are featured in this series.
2 KOLs are featured in this series.
Can 18F-Floutufolastat Bolster Detection of PCa Recurrence in Patients with Low PSA Levels After Radical Prostatectomy?
2 KOLs are featured in this series.
Related Content
© 2024 MJH Life Sciences

All rights reserved.